Home/Pipeline/DS107

DS107

Atopic Dermatitis

Phase 2Active

Key Facts

Indication

Atopic Dermatitis

Phase

Phase 2

Status

Active

Company

DS Biopharma

About DS Biopharma

DS Biopharma is a private, clinical-stage biotech company headquartered in Dublin, Ireland, built on a deep foundation in lipid science. The company is advancing a pipeline of small molecule therapeutics, with its lead programs targeting inflammatory skin diseases such as atopic dermatitis. While pre-revenue, it has established strategic partnerships and continues to progress its candidates through clinical development to address significant unmet medical needs.

View full company profile

Therapeutic Areas

Dermatology Inflammatory Diseases

Other Atopic Dermatitis Drugs

Drug	Company	Phase	Status
PEP Biologic™	Intent Biologics	Unknown	Active
HBM7575 (SKB575)	Harbour BioMed	IND Filed	Active (Global)
ITK inhibitor	Acellera	Pre-clinical	Hit-to-Lead
Encube-003	Encube Ethicals	Preclinical	Active
ENS-002 (Fermata Derm)	Concerto Biosciences	Pre-clinical	Active
Lead Program	MatriSys Bioscience	Phase 1	Active
Atopic Dermatitis Trial	Well Pharma Medical Research	Not Specified	Active
MEndoB	Micreos	Pre-clinical	Active
Atopic Dermatitis Program	Lxbio Pharmaceuticals	Pre-clinical	Active
B244	AOBiome	Phase 3	Active
CTO1681	CytoAgents	Pre-clinical	Active
AX-158	Artax Biopharma	Phase 2	Active